![Kenneth Zuerblis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Zuerblis
Directeur/Membre du Conseil chez
RESVERLOGIX CORP.
Fortune : 33 560 $ au 30/06/2026
Profil
Mr. Kenneth J.
Zuerblis, CPA, is an Independent Director at Zenith Capital Corp.
(Alberta) and an Independent Director at Resverlogix Corp.
He is on the Board of Directors at Lirum Therapeutics, Inc., Zenith Capital Corp.
(Alberta) and Resverlogix Corp.
Mr. Zuerblis was previously employed as a Chief Financial Officer, Treasurer & Executive VP by Savient Pharmaceuticals, Inc., an Independent Director by Immunomedics, Inc., a Chief Financial Officer & Senior Vice President by ImClone Systems, Inc., a Chief Financial Officer by Enzon Pharmaceuticals, Inc., and a Controller by KPMG LLP.
He also served on the board at Stemline Therapeutics, Inc., XTL Biopharmaceuticals Ltd. and New Jersey Technology Council.
He received his undergraduate degree from Seton Hall University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZENITH CAPITAL CORP. 0,17% | 19/05/2026 | 263 870 ( 0,17% ) | 26 387 $ | 31/01/2026 |
RESVERLOGIX CORP. 0,03% | 02/01/2026 | 107 062 ( 0,03% ) | 7 173 $ | 30/06/2026 |
Postes actifs de Kenneth Zuerblis
| Sociétés | Poste | Début |
|---|---|---|
| RESVERLOGIX CORP. | Directeur/Membre du Conseil | 29/09/2010 |
| ZENITH CAPITAL CORP. | Directeur/Membre du Conseil | 10/04/2013 |
| LIRUM THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/05/2023 |
Anciens postes connus de Kenneth Zuerblis
| Sociétés | Poste | Fin |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/06/2020 |
| SAVIENT PHARMACEUTICALS INC | Directeur Financier/CFO | 01/05/2012 |
| IMMUNOMEDICS, INC. | Directeur/Membre du Conseil | 08/03/2012 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Directeur Financier/CFO | 01/01/2009 |
| XTL BIOPHARMACEUTICALS LTD. | Directeur/Membre du Conseil | 01/01/2009 |
Formation de Kenneth Zuerblis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products | Health Technology |
Enzon Pharmaceuticals, Inc.
 Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Resverlogix Corp.
 Resverlogix Corp. Pharmaceuticals: MajorHealth Technology Engages in the research and development of novel biopharmaceuticals for the treatment of grievous diseases | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Zenith Capital Corp. (Alberta)
 Zenith Capital Corp. (Alberta) BiotechnologyHealth Technology Engages in the research and development of biopharmaceuticals | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
XTL Biopharmaceuticals Ltd.
 XTL Biopharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops pharmaceutical drugs for the treatment of autoimmune diseases | Health Technology |
Seton Hall University
 Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Jersey Technology Council
 New Jersey Technology Council Miscellaneous Commercial ServicesCommercial Services Provides business development, education and advocacy services | Commercial Services |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on the treatment of debilitating diseases | Health Technology |
